Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leukotriene antagonists reduce epileptic seizures-related hospitalization in older adult populations with allergic rhinitis or asthma: A population-based cohort study using the Shizuoka Kokuho database: The Shizuoka study.
Imaichi Y, Nakatani E, Fukutomi Y, Kuriyama N, Mori K, Sugawara A. Imaichi Y, et al. Among authors: nakatani e. Epilepsia Open. 2024 Feb;9(1):200-209. doi: 10.1002/epi4.12852. Epub 2023 Dec 21. Epilepsia Open. 2024. PMID: 37881138 Free PMC article.
Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease.
Hayashi H, Mitsui C, Nakatani E, Fukutomi Y, Kajiwara K, Watai K, Sekiya K, Tsuburai T, Akiyama K, Hasegawa Y, Taniguchi M. Hayashi H, et al. Among authors: nakatani e. J Allergy Clin Immunol. 2016 May;137(5):1585-1587.e4. doi: 10.1016/j.jaci.2015.09.034. Epub 2015 Nov 11. J Allergy Clin Immunol. 2016. PMID: 26559322 Clinical Trial. No abstract available.
Severe or life-threatening asthma exacerbation: patient heterogeneity identified by cluster analysis.
Sekiya K, Nakatani E, Fukutomi Y, Kaneda H, Iikura M, Yoshida M, Takahashi K, Tomii K, Nishikawa M, Kaneko N, Sugino Y, Shinkai M, Ueda T, Tanikawa Y, Shirai T, Hirabayashi M, Aoki T, Kato T, Iizuka K, Homma S, Taniguchi M, Tanaka H. Sekiya K, et al. Among authors: nakatani e. Clin Exp Allergy. 2016 Aug;46(8):1043-55. doi: 10.1111/cea.12738. Epub 2016 May 24. Clin Exp Allergy. 2016. PMID: 27041475
Identification of patterns of factors preceding severe or life-threatening asthma exacerbations in a nationwide study.
Tanaka H, Nakatani E, Fukutomi Y, Sekiya K, Kaneda H, Iikura M, Yoshida M, Takahashi K, Tomii K, Nishikawa M, Kaneko N, Sugino Y, Shinkai M, Ueda T, Tanikawa Y, Shirai T, Hirabayashi M, Aoki T, Kato T, Iizuka K, Fujii M, Taniguchi M. Tanaka H, et al. Among authors: nakatani e. Allergy. 2018 May;73(5):1110-1118. doi: 10.1111/all.13374. Epub 2017 Dec 19. Allergy. 2018. PMID: 29197099 Free PMC article.
Real-World Evidence of the Incidence of and Risk Factors for Type 1 Diabetes Mellitus and Hypothyroidism as Immune-Related Adverse Events Associated With Programmed Cell Death-1 Inhibitors.
Shimada K, Yamamoto H, Nakatani E, Kumamaru H, Nishimura S, Ichihara N, Hirahara N, Mori K, Kotani M, Miyachi Y, Miyata H. Shimada K, et al. Among authors: nakatani e. Endocr Pract. 2021 Jun;27(6):586-593. doi: 10.1016/j.eprac.2020.12.009. Epub 2020 Dec 24. Endocr Pract. 2021. PMID: 34057406
200 results